Acorda Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · TWO BLUE HILL PLAZA, PEARL RIVER, NY 10965
官方登記資料
0位追蹤者
1995成立於
關於 Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York. The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija and Ampyra (dalfampridine) in the United States.
Source: Wikipedia
產業Biological Products, (No Diagnostic Substances)
總部TWO BLUE HILL PLAZA, PEARL RIVER, NY 10965
成立時間1995
法律形式C Corporation
狀態營運中
專利424 項專利
THERAPEUTIC DOSING OF A NEUREGULIN OR A SUBSEQUENCE THEREOF FOR TREATMENT OR PROPHYLAXIS OF HEART FAILUREMX384378B · 2025
SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINEEP3355865B1 · 2024
關鍵數據
法律資訊
| 法定名稱 | Acorda Therapeutics, Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1008848在 SEC EDGAR 上查看 ↗ |
| EIN | 13-3831168 |
| 產業代碼(SIC) | 2836 |
| 登記地址 | TWO BLUE HILL PLAZA, PEARL RIVER, NY 10965 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日